Dr. Laws, former immunology leader at Sanofi, will oversee global development of Kymera’s KT-621 program. KT-621 parallel Phase 2b trials advancing in AD and asthma, with data e ...
The skills that make someone a great individual contributor are simply not the same skills that make someone a great leader, ...
Highly Experienced US-Based Public Markets Leader Strengthens Team as Company Drives Late Stage Development of LEVI-04 for Osteoarthritis ...
The House plans to vote Wednesday on a $425.1 million economic development package that carries over some of Gov. Maura ...
Experts say ErdoÄŸan's defining trait isn't Islamism or nationalism but political survival, as Trump calls Turkey's leader "a ...
The West Monroe-West Ouachita Chamber of Commerce is now accepting enrollment for its Fall Mentoring Program. The program is ...
Vermont students will soon have the chance to benefit from a worldwide development program. The partnership will take place ...